Contrary to popular belief, Addyi is not the female Viagra. That's the message drug-maker Sprout must get across to doctors and patients in the coming weeks.
Sprout plans to hire 200 sales reps, targeting 30,000 doctors, to accompany the drug's launch.
Allergan executives attributed strong sales of branded products to recent investments in direct-to-consumer advertising.
The drugmaker, which sells prostate-cancer treatment Xtandi, wants social-media users to help spread the word about the disease
The "Surprise, it's insulin" campaign follows criticism of the lower-than-expected sales of the inhaled insulin since its launch in February.
Pfizer, through the Better Business Bureau's National Advertising Division, disputes that Novartis's Theraflu 'starts to work in the body in 5 minutes.'
Arena's recent quarter shows weight-loss drug Belviq is on the rise. It follows a DTC push and the recent addition of reps by co-marketer Eisai.
Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.
The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.
The drugmaker received a notice from the advertising watchdog over promotion of hep. B treatment Viread in a sponsored link on Google AdWords.
A US Pharma juror's—and silver Lions Health winner's—opinion on why the Americans didn't fare well in Cannes, and tips for improvement
Celebrity endorsement, co-pay cards and online edutainment are some of the ways marketers are dueling for attention in the prescription omega-3 space.
With pollen season approaching its peak, drugmakers are educating doctors on a new class of allergy tablets. It could be a while before they're made available for patients.
The AIDS Healthcare Foundation took out an ad in some WSJ editions saying the drug threatens to "break the bank."
Actress, choreographer and "So You Think You Can Dance" judge Debbie Allen has signed on to participate with the drugmaker's type 2 diabetes awareness and wellness program.
AbbVie's "Perspectives—Art, Inflammation and Me," an exhibit centered around inflammatory diseases, looks to offer patient perspective through an artistic medium.
These ads take aim at the aging male population. How well do they do at hitting their target?
Well-conceived disease awareness communications can be a powerful vehicle in establishing an urgent, emotional connection with an audience
These days, hitting the target in ads is ever more critical. These five ads are up to the challenge.
Displaying an in-your-face, post-digital sensibility, these global campaigns tell provocative stories to instigate behavioral change
The EpiPen manufacturer's latest effort: an e-book that shows children making allergy-friendly swaps at a school event.
The company is supporting its professional pitch for the acne drug with a micro-targeted marketing strategy.
Images that dramatize physical problems with an almost nightmarish spin make for compelling brand messages in six top-notch advertisements
How Shire's new campaign seeks to help diabetics start off on the right foot
The company narrowed its second quarter loss, but said its national TV campaign is driving an uptick in consumer interest.
Novo redoubled its Victoza marketing efforts after a recent setback, and that's made things tougher for GLP-1 rivals Bristol-Myers Squibb and AstraZeneca.
The drug maker's broadcast-heavy "OAB reality" campaign stresses the emotional toll on women.
23andMe aired its first TV ad Monday, in a bid to build the audience for DNA sequencing.
Print reaches readers when they are engaging with ideas. These ads show how to make that connection pay off.
Whether serious or humorous, the right "line" can stand alone, transcend the need for an accompanying visual, and become iconic in its own right.
Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.